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Abstract
Background: Ziziphus jujuba, which is known as “Annab” or “Onnab” in Iran, is an effective compound against some cancer cell lines.
The present study aimed to investigate the anti-mutagenic and anticancer effects of the aqueous extract of Z. jujuba on C643 human
thyroid carcinoma cells.
Methods: C643 cells were cultured in (Roswell Park memorial institute) RPMI 1640 medium (Sigma) supplemented with 10% fetal
bovine serum (FBS), penicillin-streptomycin, and L-glutamine. After incubating the cultures at 37ºC with 5% CO2, MTT assay was used
to determine the inhibitory effect of Z. jujuba on cell proliferation. Cell cycle progression was monitored by sub-G1 apoptosis assay
using flow cytometry. Finally, anti-mutagenicity properties of the extract were evaluated using a standard reverse mutation assay
(Ames test), which was performed with a histidine auxotroph strain of Salmonella typhimurium (TA100) and exposure to a carcino-
genic substance (sodium azide).
Results: The aqueous extract of Z. jujuba inhibited the growth of C643 cells in a concentration range of 0.5 - 2 mg/mL and exhibited
cytotoxic effects on C643 cells in a concentration-dependent manner (IC50: 1.671 mg/mL). The mechanism of action was the induction
of apoptosis in the cells. The results of Ames test indicated a significant difference in the anti-mutagenic effects of Z. jujuba aqueous
extract and controls (distilled water and sodium azide) (1.671 mg/mL) (P < 0.01). In addition, the herbal extract prevented reverted
mutations and the hindrance percent was 87.97%.
Conclusions: According to the results, the aqueous extract of Z. jujuba fruit exerted anti-proliferative and apoptotic effects on C643
thyroid carcinoma cell lines and may be potentially useful as an anticancer agent.
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1. Background
Cancer is among the three major causes of death in
Iran. According to the reports of the Iranian ministry of
health, more than 35,000 cancer deaths occur each year
(1). Increased incidence of cancer is a consequence of pop-
ulation aging and high prevalence of obesity, smoking
habits, environmental carcinogens, and sedentary lifestyle
(2). Studies on natural compounds, especially medicinal
plants, have confirmed their anticancer effects; therefore,
these products could be used independently or in the form
of complementary therapy as a cost-effective approach to
cancer prevention and treatment (3).
Common jujube (Ziziphus jujuba) belongs to the Rham-
naceae family and grows in some regions in Asia, including
Iran, India, and China. Jujube is a tree similar to olive tree,
with red/brown sweet fruits that contain a single hard seed
(4). The Persian name of this fruit is “Annab” or “Onnab”. Ac-
cording to the references of the Persian medicine, jujube
can produce new blood cells and refine the blood from
harmful humor (blood purifier). Furthermore, jujube is
recommended for subsiding coughs and the treatment of
some liver, stomach, and bladder disorders (5).
Z. jujuba contains vitamin C, phenolic acids, flavonoids,
triterpenic acids, and polysaccharides. Moreover, several
studies have confirmed the anticancer, anti-inflammatory,
antioxidant, hepatoprotective, and gastrointestinal pro-
tective properties of this plant (6). The effectiveness of Z. ju-
juba has also been demonstrated against some cancer cell
lines. For instance, Z. jujuba extracts could be used inde-
pendently or in combination with other plants to induce
apoptosis and exert cytotoxic effects on breast cancer (7-
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9), human hepatoma (HepG2) (10), human cervical carci-
noma, human larynx carcinoma, T-cell leukemia (11), and
melanoma cell lines (12).
To date, no studies have evaluated the anti-mutagenic,
anti-proliferative, and cytotoxic effects of Z. jujuba extracts
on thyroid carcinoma cells. Considering the rising trend of
thyroid cancer (3, 13, 14), the present study aimed to investi-
gate the anti-mutagenic and anticancer effects of Z. jujuba
in C643 as human thyroid carcinoma-derived cells.
2. Methods
2.1. Plant Extraction
Z. jujuba fruits were purchased from a local herbal mar-
ket in Tehran, Iran, and the authenticity was approved by
Dr. G. Amin (Herbarium of Tehran University of Medical Sci-
ences, Tehran, Iran) (Voucher No: PMP 697). The fruits were
dried, ground, and extracted by boiling in distilled water
for 30 minutes. The mixture was filtered and dried using a
freeze dryer (8, 9), and the obtained dry powder was used
for further assessment.
2.2. Total Phenolic Content
The total phenolic content (TPC) of the aqueous extract
of Z. jujuba was determined based on the Folin-Ciocalteu
method with minor modifications (15).
To prepare the calibration curve, one milliliter of the
aliquot of 75, 100, 150, and 200 µg/mL hydro-ethanolic
(50:50) gallic acid (GAE) solutions was mixed with five
milliliters of Folin-Ciocalteu reagent (diluted 10-fold) and
four mL (75 mg/mL) of sodium carbonate. The absorption
was read at 765 nm after 30 minutes, and the calibration
curve was drawn. Afterwards, one milliliter of the herbal
extract (1 mg/mL) was mixed with the same reagents as de-
scribed above, and the absorption was measured to verify
the TPC.
All the measurements were repeated three times, and
the TPC of the Z. jujuba extract was expressed as mean and
standard deviation of the µg of the (GAE) equivalents per
milligram of the extract (y = 0.0088x - 0.106).
2.3. Cell Culture
The thyroid carcinoma cell line (C643) was purchased
from Pasteur Institute of Iran. The cells were cultivated in
T75 tissue culture flasks in RPMI-1640 medium, which was
supplemented with 10% fetal bovine serum and incubated
in a humidified incubator containing 5% CO2 at the tem-
perature of 37°C.
After the growth and reproduction of the cells, ad-
herent cells were separated from the flask bottom using
trypsin (0.25%), and 5,000 cells were transferred to the
flasks. All the examinations were conducted after 18 hours
of incubation in the flasks of the cell culture plates.
2.4. MTT Assay
To determine cell viability, dimethylthiazol diphenyl
tetrazolium bromide (MTT) assay and the microculture
tetrazolium technique have been suggested, which were
conducted quantitatively in the present study. The numer-
ical statics could be obtained from the formazan crystals
that are originated from metabolically active cells. The mi-
tochondrial dehydrogenase of live cells caused color re-
duction in the mentioned cells, which contained purple
crystals. After 18 hours, various concentrations of the aque-
ous extract of Z. jujuba were added to the cells, and the
plates were incubated with 5% CO2 at the temperature of
37°C for 48 hours.
In the live cells, MTT was reduced into an insoluble
purple product (formazan), which was the resultant of mi-
tochondrial reductase activity and the base of MTT stain-
ing. After the incubation of C643 cells for 24 hours, which
were seeded into a 96-well plate (5 - 7× 103 cells per well),
various concentrations of the aqueous extract of Z. jujuba
were added to each well (incubated with 5 mg/mL of MTT
for four hours) and incubated for 48 hours. The super-
natant was removed after centrifugation. Finally, 100µL of
dimethyl sulfoxide was added to each well (total: 48) and
used for the MTT assay. The absorbance of the cells was
measured using an ELISA plate reader at 570 nm. Addition-
ally, the toxicity level was calculated using the following
formulas (16):
Cytotoxicity (%) = 1− MeanAbsorbance of Toxicant
MeanAbsorbance of Toxicant
× 100
(1)
(2)V iability (%) = 100− Cytotoxicity (%)
To reduce the test error level, the absorbance level was
read after adding the MTT strain to some of the plate wells
without the cells (followed by the other wells) and ulti-
mately subtracted from the total absorbance.
2.5. Determining IC50
After 48 hours, Probit analysis was applied in the
Pharm/PCS-Pharmacologic Calculation System Modulus
(Springer-Verlag, USA) to determine the inhibitory concen-
tration 50% (IC50) of the Z. jujuba extract in the C643 cells.
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2.6. Sub-G1 Apoptosis Flow Cytometric Analysis
In this stage, we used the method proposed by Karimi
et al. (17) for the analysis of the cells in terms of sub-G1 apop-
tosis. Moreover, the flow cytometric analysis of propidium
iodide (PI)-labeled cells was performed to determine the
cellular DNA content. The cells were grown to an exponen-
tial phase, seeded at the density of 106 cells per well into a
24-well plate, and incubated for 24 hours.
In the following stage, the cells were treated by the IC50
and incubated for 48 hours. Afterwards, they were har-
vested, fixed in ice-cold 70% ethanol, stored at the temper-
ature of 4°C, washed with phosphate buffered saline (PBS)
(pH: 7.2), treated with 25 µg/mL RNase at the temperature
of 37°C for 15 minutes, and stained with 50 µg/mL of PI for
20 minutes after incubation. Finally, the PI fluorescence of
individual nuclei was measured using the FACS caliber ap-
paratus (18).
2.7. Apoptotic Changes in Plasma Membrane
An Annexin-V-FLUOS staining kit (Roche) was used for
annexin V binding, and approximately 106 cells (deter-
mined by a hemocytometer) were analyzed in accordance
with the protocol provided by the manufacturer. In brief,
the cells were re-suspended in the Annexin-V-FLUOS label-
ing solution after they were washed once with PBS. After-
wards, the cells were incubated at the temperature of 15 -
25°C for 10 - 15 minutes, and the samples were measured
using the Becton-Dickinson flow cytometer (19).
2.8. Anti-Mutagenesis Assay
For the Ames test, we used a fresh bacterial culture of
Salmonella typhimurium TA100. Bacterial concentration of 1
- 2× 109 cells/mL. The IC50 of the Z. jujuba extract was added
to a test tube containing overnight fresh bacterial culture
(0.5 mL), histidine (0.5 mL), biotin solution (0.5 mM his-
tidin/0.5 mM biotin), top agar (10 mL) (50 g/l Agar + 50 g/l
NaCl), and sodium azide (1.5 µg/mL) as a carcinogen. Fol-
lowing that, the contents of the tube were transferred to
the glucose agar medium (40% glucose), and after shak-
ing for three seconds, were incubated at the temperature
of 37°C for 48 hours. Each treatment was repeated three
times. After 48 hours of incubation at 37°C, the reversed
colonies were counted, and antioxidant activity (preven-
tion percentage) was calculated based on the following for-
mula (20):
(3)Prevention Percentage =
(
1− T
M
)
× 100
T represents the reversed colonies in each Petri dish
with the carcinogen and herbal extract, and M is the re-
versed colonies in the Petri dishes of positive control (i.e.,
mutagen).
2.9. Statistical Analysis
Data analysis was performed in SPSS version 17. Results
were expressed as the mean and standard deviation of the
indicated number of the independent experiments. In ad-
dition, analysis of variance (ANOVA) and Tukey’s post-hoc
test were used to compare the mean values, and P-value of
less than 0.05 was considered statistically significant.
3. Results
Mean TPC of the Z. jujuba aqueous extract was esti-
mated at 0.85± 0.1µg of GAE/mg of the extract.
3.1. Vital Capacity Test
To investigate the potential effects of the Z. jujuba aque-
ous extract, the cells were exposed to the extract at the
concentrations of 0, 0.5, 0.75, 1, 1.5, 1.8, and 100 mg/mL for
48 hours (8, 9). According to Figure 1, the herbal extract
induced cell apoptosis in a dose-dependent manner (P <
0.01). Mean IC50 of the C643 cell line was calculated to be
1.671± 0.14 mg/mL after 48 hours.
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Figure 1. Anti-proliferative effects of Z. jujuba aqueous extract on C643 cell line
3.2. Sub-G1 Apoptosis
In the present study, the effects of the Z. jujuba aque-
ous extract on the cell cycle progression were assessed us-
ing flow cytometry with 1.671 mg/mL of the extract to de-
termine its inhibitory mechanism. As is depicted in Figure
2, treatment of the cells by the herbal extract was associ-
ated with a significant increase in the sub-G1 apoptotic con-
tent. Sub-G1 was formed in 0.64% of the cells (Figure 2A),
while the concentration of 1.67 mg/mL resulted in the sub-
G1 phase in 50.46% of the cells (Figure 2B) in the absence of
the herbal extract.
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Figure 2. Effects of Z. jujuba aqueous extract on cell cycle progression at 48 hours: A,
control; B, treatment (1.67µg/mL).
3.3. Annexin V Assay
Several hallmark features of apoptosis were developed
in the cancer cells upon treatment with the Z. jujuba ex-
tract, including phosphatidylserine exposure. The cancer
cells exposed phosphatidylserine on their plasma mem-
brane within 48 hours of exposure to the herbal extract
(1.671 mg/mL). Level of annexin V binding to the phos-
phatidylserine molecules exposed on the cell surface was
determined as well (Figure 3). Approximately 67.9% of the
cells exposed phosphatidylserine after 48 hours of extract
treatment when the proportion of the annexin V-bound
cells was quantitated (P < 0.01).
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Figure 3. Apoptotic effects of Z. jujuba aqueous extract on cancer cells at 48 hours:
A, control; B, treatment (1.67 mg/mL).
3.4. Anti-Mutagenic Effects of Z. Jujuba Aqueous Extract
The results of colony counting in the Ames test using
1.671 mg/mL of the Z. jujuba aqueous extract showed a sig-
4 Int J Cancer Manag. 2018; 11(7):e65820.
Hashem Dabaghian F et al.
nificant difference in the anti-mutagenic effect on colony
growth compared to sodium azide and distilled water (P <
0.01). In addition, the Z. jujuba aqueous extract prevented
reverted mutations with the hindrance percent of 87.97%
in the anti-mutagenicity test.
4. Discussion
Current treatments for malignancies are associated
with a wide range of adverse complications. In recent
years, an increased tendency has been reported toward dis-
covering natural compounds, particularly plant-based al-
ternatives, as preventive or therapeutic agents in cancer
treatment (21-23). Some reports have confirmed the effi-
cacy of some fruits and vegetables in reducing the risk of
chronic diseases, including cancer (24-26).
Since mutagenesis, tumor initiation, and progression
are closely correlated with the production of free radi-
cals and subsequent oxidative stress and inflammation
(27), plants with antioxidant and anti-inflammatory prop-
erties (e.g., Z. jujuba) are among the viable options as an-
ticancer agents considering their ability to scavenge re-
active radical species and decrease DNA damage (28-30).
Flavonoids, ascorbic acid, anthocyanin, and phenolic acids
are the main antioxidant compounds in Z. jujuba (6, 31).
Flavonoids are able to prevent or treat cancers by trigger-
ing apoptosis (32-34). In addition, Z. jujuba contains ter-
penoids (6), which are a class of cancer chemopreventive
and anti-tumor agents (35, 36). According to the literature,
11 triterpenoic acids have been derived from Zizyphus ju-
juba fruits (37).
The primary results of the current research demon-
strated that the Z. jujuba extract inhibited the growth of
C643 cells within a concentration range of 0.5 - 2 mg/mL.
Further analysis indicated that the extract could cause
morphological changes, representing apoptosis in cul-
tured C643 cells. Moreover, Z. jujuba had cytotoxic effects
on C643 cells in a concentration-dependent manner (IC50:
1.671 mg/mL). The sub-G1 apoptosis assay confirmed that Z.
jujuba induced apoptosis in C643 cells, while the results of
the MTT and sub-G1 assays clearly indicated the cytotoxic
effects of Z. jujuba on C643 cells.
According to the results of the present study, the pre-
vention percentage of the aqueous extract of Z. jujuba was
87.97%. According to the Ames theory, when the prevention
percentage is less than 25%, 25 - 40%, and more than 40%,
the anti-mutagenic effects of interventional chemicals are
considered to be negative, moderate, and strong, respec-
tively (38, 39).
Previous studies have indicated the significant anti-
proliferative effects of the Z. jujuba fruit on various cancer
cells. For instance, Huang et al. reported the anticancer ac-
tivities and apoptosis induction of the Z. jujuba fruit in hu-
man hepatoma cells (10). Findings of a study investigating
the effects of Z. jujuba on HeLa, Hep-2, and leukemia cells
showed similar results (11). In addition, previous studies
have confirmed the anti-proliferative and apoptotic effects
of bioactive constituents of the Z. jujuba fruit extract (es-
pecially triterpenes) on breast cancer cell lines (MCF-7 and
SKBr3) (7).
In a research in this regard, Hoshyar et al. reported
the cytotoxic effects of Z. jujuba on breast cancer cells.
The hematological and biochemical changes associated
with Z. jujuba treatment result in the antioxidant and anti-
inflammatory effects of this plant.
Z. jujuba has been shown to exert preventive effects
against anemia, lymphocytosis, and neutrophilia caused
by N-nitrosomethylurea as mammary gland carcinogens
in rats. In addition, low levels of serum lactate dehydroge-
nase, alkaline phosphatase, total protein, and albumin in
the Z. jujuba group indicated that this plant could control
the cellular destruction caused by tumor progression (8).
In another study, Abedini et al. reported the effects of Z.
jujuba on OV2008 (cervical cancer cells) and MCF-7 (breast
cancer cells). Moreover, apoptosis induction with the en-
hanced expression of the Bax gene and decreased Bcl2 gene
was observed (9). Bax and Bcl2 are the genes that regulate
apoptosis, and the balance between their expression and
distribution is the main determinant of cell death (40).
Similarly, Hung et al. reported the anti-proliferative
effects of the deproteinized polysaccharide derived from
the Z. jujuba fruit on melanoma cells. In addition, the au-
thors claimed that apoptosis induction is one of the mech-
anisms of action associated with increased caspase-3 and
caspase-9 activities (12). Apoptosis induction was also ob-
served in the present study, which is in congruence with
the previous findings in this regard (7, 10, 11). Apoptosis
is a vital component of normal cell turnover in body tis-
sues, which normally occurs during development and ag-
ing, and its inhibition is considered to be an important fac-
tor in many cancers (32-34, 41, 42).
In the current research, we attempted to assess the
anti-mutagenic effects of Z. jujuba extract using the Ames
test. The Ames test is one of the most recent tests to as-
say anti-mutagenesis using bacteria with special mutants.
The Ames test applied the mutant strains of Salmonella
typhimurium (TA100) that cannot grow in the absence of
histidine amino acid since a mutation has occurred in
a gene encoding one of the nine enzymes used in the
pathway of histidine synthesis, preventing the translation
of a functional enzyme; consequently, the conversion of
the catabolic intermediate into histidine cannot be com-
pleted. Therefore, the Ames mutants are auxotrophic and
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known as histidine-dependent or his- (pronounced his-
minus) mutants since they can only grow if histidine is
supplied in the growth medium (19, 20). Despite the com-
mon application of the Ames test, other tests should also
be developed to be used beforehand in order to confirm
the anticancer effects of various compounds.
In the present study, the sub.G1 assay confirmed that
Z. jujuba could induce apoptosis in C643 cells (Figures 2
and 3). In this regard, Abedini et al. reported the effects
of Z. jujuba on the gene expression involved in the cell cy-
cle regulation. Furthermore, they stated that Z. jujuba in-
creased p53, p27, and p21 mRNA levels, while decreasing the
CD1 mRNA level and changing the expression of Bax and
Bcl2 (apoptosis-regulating genes) and their ratio (9).
4.1. Conclusion
For the first time, we showed that the aqueous extract
of Ziziphus jujuba fruit has anti-proliferative and apoptotic
effects on C643 thyroid carcinoma cell lines. Our findings
indicated that Z. jujuba is a valuable fruit with potential
benefits in cancer prevention and treatment. It is recom-
mended that further investigation be conducted to assess
the anticancer properties of Z. jujuba in animal and human
models.
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